We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · March 02, 2021

Higher Risk of Acute Coronary Syndrome in Patients With COPD Using 2 vs 1 Long-Acting Bronchodilators

BMJ Open Respiratory Research


Additional Info

Disclosure statements are available on the authors' profiles:

BMJ Open Respiratory Research
Is the Use of Two Versus One Long-Acting Bronchodilator by Patients With COPD Associated With a Higher Risk of Acute Coronary Syndrome in Real-World Clinical Practice?
BMJ Open Respir Res 2021 Jan 01;8(1)00, L Parkin, S Williams, D Barson, K Sharples, S Horsburgh, R Jackson, J Dummer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading